Invesco Ltd. Coherus Bio Sciences, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 61,229 shares of CHRS stock, worth $45,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,229

Previous 52,101 17.52%

Holding current value

$45,309

Previous $90,000 30.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.99 - $1.8 $9,036 - $16,430	9,128 Added 17.52%	61,229 $63,000
Q2 2024 Aug 13, 2024	BUY	$1.58 - $2.51 $7,565 - $12,017	4,788 Added 10.12%	52,101 $90,000
Q1 2024 May 14, 2024	SELL	$2.02 - $3.14 $169 - $263	-84 Reduced 0.18%	47,313 $113,000
Q4 2023 Feb 12, 2024	BUY	$1.59 - $3.85 $14,804 - $35,847	9,311 Added 24.45%	47,397 $157,000
Q3 2023 Nov 13, 2023	SELL	$3.74 - $5.45 $890,396 - $1.3 Million	-238,074 Reduced 86.21%	38,086 $142,000
Q2 2023 Aug 11, 2023	SELL	$3.79 - $8.3 $22,683 - $49,675	-5,985 Reduced 2.12%	276,160 $1.18 Million
Q1 2023 May 12, 2023	SELL	$5.89 - $10.52 $351,680 - $628,128	-59,708 Reduced 17.47%	282,145 $1.93 Million
Q4 2022 Feb 13, 2023	BUY	$5.69 - $10.07 $149,191 - $264,035	26,220 Added 8.31%	341,853 $2.71 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $123,037 - $238,009	-17,160 Reduced 5.16%	315,633 $3.03 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $26,164 - $59,071	4,465 Added 1.36%	332,793 $2.41 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $217,406 - $326,706	19,909 Added 6.46%	328,328 $4.24 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $1.77 Million - $2.12 Million	-111,901 Reduced 26.62%	308,419 $4.92 Million
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $465,584 - $653,213	-36,718 Reduced 8.03%	420,320 $6.76 Million
Q2 2021 Aug 17, 2021	BUY	$12.95 - $15.41 $301,424 - $358,683	23,276 Added 5.37%	457,038 $6.32 Million
Q1 2021 May 17, 2021	SELL	$14.42 - $21.39 $7.91 Million - $11.7 Million	-548,803 Reduced 55.85%	433,762 $6.34 Million
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $993,666 - $1.14 Million	60,004 Added 6.5%	982,565 $17.1 Million
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $981,053 - $1.12 Million	-56,350 Reduced 5.76%	922,561 $16.9 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $1.09 Million - $1.44 Million	75,389 Added 8.34%	978,911 $17.5 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $7.11 Million - $13.7 Million	608,983 Added 206.76%	903,522 $14.7 Million
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $6.9 Million - $9.03 Million	-422,783 Reduced 58.94%	294,539 $5.3 Million
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $4.8 Million - $6.88 Million	294,236 Added 69.55%	717,322 $14.5 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $22.1 $534,309 - $901,392	40,787 Added 10.67%	423,086 $9.35 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $3.2 Million - $5.93 Million	382,299 New	382,299 $5.22 Million

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $57.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account